Evaluation of Novel Lung Function Parameters in Patients With Pulmonary Hypertension (PH)
NCT ID: NCT03667794
Last Updated: 2018-09-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
75 participants
OBSERVATIONAL
2015-07-01
2017-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Novel Lung Function Parameters in Patients With Bronchial Asthma
NCT03820427
Evaluation of Novel Lung Function Parameters in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02827721
Evaluation of Novel Lung Function Parameters and Quantitative Computed Tomography (qCT) in Patients With Pulmonary Disease
NCT02826265
Observational Study of Obstructive Lung Disease (NOVELTY)
NCT02760329
The Natural History of Small Airways Physiology in Diseased and Healthy States
NCT00677560
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PH patients
Patients with known or first diagnosis of PH
body plethysmography
measurement of conventional lung function parameters
impulse oscillometry
measurement of central and peripheral airway resistance
multiple breath washout
measurement of ventilation heterogeneity
healthy controls
Healthy controls had normal lung function testing including whole-body plethysmography and transfer factor, no previously diagnosed pulmonary disease as well as no respiratory symptoms.
body plethysmography
measurement of conventional lung function parameters
impulse oscillometry
measurement of central and peripheral airway resistance
multiple breath washout
measurement of ventilation heterogeneity
non-healthy controls
Non-healthy controls were allowed to have stable pulmonary comorbidities including chronic obstructive pulmonary disease (COPD), sarcoidosis, asthma, or fibrosis as well as non-pulmonary comorbidities.
body plethysmography
measurement of conventional lung function parameters
impulse oscillometry
measurement of central and peripheral airway resistance
multiple breath washout
measurement of ventilation heterogeneity
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
body plethysmography
measurement of conventional lung function parameters
impulse oscillometry
measurement of central and peripheral airway resistance
multiple breath washout
measurement of ventilation heterogeneity
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* unable or unwilling to participate
18 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitätsmedizin Mannheim
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Frederik Trinkmann
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frederik Trinkmann, MD
Role: PRINCIPAL_INVESTIGATOR
Universitätsmedizin Mannheim
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MBW-PH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.